Financial Ratios

LINK PHARMA CHEM LTD.

NSE : NABSE : 524748ISIN CODE : INE302F01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE28.510.11 (+0.39 %)
PREV CLOSE ( ) 28.40
OPEN PRICE ( ) 29.55
BID PRICE (QTY) 28.51 (7)
OFFER PRICE (QTY) 28.86 (2)
VOLUME 327
TODAY'S LOW / HIGH ( )28.30 29.55
52 WK LOW / HIGH ( ) 2842.8
NSE
This Company is not listed in NSE
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.31-3.071.474.242.44
   CEPS(Rs)-0.19-0.743.556.334.41
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)28.5130.8733.8732.6028.29
   Tax Rate(%)26.7528.8626.1928.2235.37
Margin Ratios
   Core EBITDA Margin(%)0.51-2.175.965.988.52
   EBIT Margin(%)-2.47-3.494.255.746.09
   Pre Tax Margin(%)-5.51-6.412.294.894.82
   PAT Margin (%)-4.04-4.561.693.513.12
   Cash Profit Margin (%)-0.33-1.104.075.255.63
Performance Ratios
   ROA(%)-4.19-4.672.136.844.82
   ROE(%)-7.79-9.484.4313.929.04
   ROCE(%)-3.03-4.477.3816.5713.58
   Asset Turnover(x)1.041.021.261.951.55
   Sales/Fixed Asset(x)1.612.022.914.382.99
   Working Capital/Sales(x)22.9757.3912.7718.105.93
Efficiency Ratios
   Fixed Capital/Sales(x)0.620.490.340.230.33
   Receivable days72.9753.6042.3637.2055.28
   Inventory Days85.71112.6780.0824.7221.64
   Payable days76.2491.5195.1156.98101.20
Valuation Parameters
   PER(x)0.000.0024.859.509.68
   PCE(x)-177.89-56.8610.316.365.36
   Price/Book(x)1.191.361.081.230.84
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.820.930.640.440.27
   EV/Core EBITDA(x)65.63-2928.749.665.843.11
   EV/EBIT(x)-33.06-26.6615.067.614.39
   EV/CE(x)1.121.211.041.120.36
   M Cap / Sales0.590.630.420.330.30
Growth Ratio
   Net Sales Growth(%)-14.93-22.86-27.6453.8536.68
   Core EBITDA Growth(%)3425.26-100.37-35.7633.679.61
   EBIT Growth(%)39.93-163.36-46.3945.0317.55
   PAT Growth(%)24.62-308.33-65.2373.4614.21
   EPS Growth(%)24.62-308.33-65.2373.4614.20
Financial Stability Ratios
   Total Debt/Equity(x)0.460.670.580.440.29
   Current Ratio(x)1.111.051.211.281.63
   Quick Ratio(x)0.540.480.370.831.36
   Interest Cover(x)-0.81-1.202.166.814.81
   Total Debt/Mcap(x)0.390.490.540.360.35

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.